What’s inside:
- How CMS TEAM mandates change surgical financial accountability in 2026
- Why bundled payments expose hidden risk in traditional surgical case costing
- The data gaps that prevent accurate case-level cost attribution
- What hospitals need to succeed under TEAM target pricing
- How real-time, point-of-use data enables defensible surgical case costing
CMS’s Transforming Episode Accountability Model (TEAM) is changing how hospitals are measured, reimbursed, and evaluated for care. For hospital leadership, administration, and financial teams, the implication is straightforward. As a bundled-payment model, part of a hospital’s financial success under TEAM depends on understanding the true cost of surgery at the case level, where the largest and most controllable portion of episode cost is established.
Under TEAM, hospitals are exposed to bundled payment financial accountability that ties reimbursement directly to episode-level cost performance. Many organizations believe they already have this visibility. However, with manual tracking methods, most surgical case costing models rely on assumptions, averages, and retrospective reconciliation. Under a payment model built around externally defined target prices, that gap creates real financial risk.
Why Bundled Payments Require Precision Surgical Case Costing
TEAM introduces accountability for the total cost of care across five defined surgical episodes. Hospitals no longer control pricing through internal budgeting alone. Instead, they are measured against target prices that assume cost discipline, consistency, and transparency.
This shifts surgical case costing from a reporting exercise to a strategic operating capability. Leaders need to understand not just whether a service line is profitable, but why. That understanding requires clarity on what happens inside the operating room, where supply choices, utilization patterns, and provider-level cost variation directly influence surgical cost management and, in turn, impact whether the total episode comes in under or over the target price.
Without accurate case-level cost attribution, financial performance becomes reactive. Variance is discovered after the fact. Conversations with surgeons become difficult because the data lacks credibility. Improvement efforts stall because leaders are debating the numbers instead of acting on them.
Surgery Is Not the Entire Bundle, but It Is the Foundation
CMS TEAM bundles include costs beyond the operating room, including post-acute care, readmissions, and downstream services across the episode window. Financial performance under TEAM depends on managing the full continuum of care, not just the surgical event itself.
However, surgery remains one of the largest and most immediately controllable cost drivers within the episode. Implant selection, supply utilization, and intraoperative decisions establish a significant portion of the baseline cost structure for the entire bundle. When surgical case costing is inaccurate, downstream cost management becomes reactive rather than strategic.
Hospitals cannot effectively manage bundled payment financial accountability if they lack confidence in the starting point of the episode.
Accurate, case-level cost attribution in surgery provides critical financial clarity required to evaluate post-acute performance, assess readmission risk, and model total episode economics with confidence.
In this way, surgical case costing does not replace episode management. It enables it.
The Data Gap: Why ERP and Manual Records Fail Case Costing
Most hospitals have established ERP systems, preference cards, and charge capture workflows. On paper, the infrastructure for surgical case costing exists. In reality, the data feeding those systems is often incomplete or inaccurate.
The problem is not system availability. It is the lack of operating room supply cost visibility and reliable surgical-cost data. Under TEAM, this gap makes it difficult to reconcile internal cost models with externally evaluated episode performance. This disconnect often surfaces only after performance has already been measured.
Where does surgical cost data break down?
In many organizations:
- Supplies are documented based on expected usage rather than actual consumption
- Manual workflows introduce missed, delayed, or incorrect capture
- Reconciliation occurs days or weeks after the case
- Case-level attribution to individual providers is incomplete or inconsistent
- The item master does not include consignment or bill-only items
Over time, these gaps create a false sense of precision. Cost reports appear detailed, but the underlying data is not trustworthy enough to support TEAM-driven decision-making. When reimbursement is matched against target prices, even small inaccuracies can have outsized financial consequences.
Essentials for Accurate Case-Level Costing Under TEAM
Under TEAM, hospital leaders must be able to explain cost performance with confidence. That means knowing the true supply cost of a procedure as it is performed today, not as it was modeled months ago. It means understanding where variation exists across surgeons and service lines, and which products or decisions are driving that variation.
What must surgical case costing data include?
To clearly understand true financial performance, particularly under TEAM, surgical case costing data must:
- Reflect actual products used in each case
- Be captured as close to real time as possible
- Be attributable to procedures and providers
- Be consistent enough to support longitudinal analysis
At that point, case costing stops being a finance-only exercise and becomes a shared language across clinical and administrative teams.
Snap&Go Captures the Truth at the Point of Use

Accurate surgical case costing starts with accurate data, and accuracy begins at the point of use. IDENTI’s Snap&Go was designed to capture what actually happens in the operating room, without adding burden to clinical teams.
Using computer vision, Snap&Go identifies products via a camera to capture real-time surgical usage data. This eliminates dependence on preference cards, manual documentation, and post-case correction. Each product is assigned to the specific case and provider, creating an objective and complete record of surgical consumption that can be confidently incorporated into episode-level financial models.
By capturing usage in real time, Snap&Go closes the data gap that undermines most case costing efforts. The result is a reliable foundation for understanding true cost at the level that TEAM requires.
| Costing Capability | Traditional Surgical Case Costing (ERP and Manual) | Snap&Go Automated Point-of-Use Costing |
|---|---|---|
| Data Source | ERP and preference card estimates based on expected usage | Real-time computer vision capture at the point of use |
| Accuracy | High variance (±15–20%) due to manual entry and assumptions | High precision based on actual products used |
| Reconciliation Timing | Retrospective reconciliation days or weeks after the case | Immediate, real-time reconciliation during the case |
| Case-Level Cost Attribution | Partial or inferred case-level cost attribution | Complete case-level cost attribution by procedure and provider |
| Operating Room Supply Cost Visibility | Limited visibility inside the OR | Full operating room supply cost visibility |
| TEAM Readiness | High TEAM Model Financial Risk due to delayed and estimated data | High financial control aligned with CMS TEAM requirements |
Comparison of traditional surgical case costing versus automated point-of-use costing for managing CMS TEAM bundled payment risk.
Turning Accurate Data Into Actionable Insight
When surgical case costing is built on trusted data, its impact extends well beyond finance.
- Hospital leadership gains a clear view of how surgical performance aligns with TEAM target prices
- Financial teams can identify cost drivers and model improvement opportunities without questioning the inputs
- Surgeons and clinical leaders see transparent data tied directly to practice patterns
Most importantly, conversations about cost shift from opinion to evidence. Variation becomes visible and explainable. Improvement becomes collaborative rather than corrective.
That alignment is critical under TEAM, where financial performance and clinical decision-making are inseparable.
Thriving Under TEAM Requires Knowing the True Value of Surgery
TEAM does not reward averages. It rewards precision, transparency, and control. Hospitals relying on delayed or estimated data will struggle to maintain margins as CMS target prices tighten, increasing financial exposure over time.
By investing in automated surgical case costing supported by real-time utilization data and accurate case-level attribution, hospitals can turn bundled payment accountability into a competitive advantage.
Snap&Go enables that foundation by ensuring hospitals know exactly what is used in the OR, by whom, and for which case. Under TEAM, knowing the true value of surgery is not optional. It is essential.
Contact us today to understand your true surgical spend and prepare for CMS TEAM success.



